The first brain images produced simultaneously with a prototype MR/PET scanner were shown at the Siemens Medical Solutions booth and in a scientific session in Berlin. The device, currently in development at a Siemens lab, integrates a PET detector into the bore of a 3T scanner.
The first brain images produced simultaneously with a prototype MR/PET scanner were shown at the Siemens Medical Solutions booth and in a scientific session in Berlin. The device, currently in development at a Siemens lab, integrates a PET detector into the bore of a 3T scanner.
A mock-up of the underlying concept appeared at the RSNA 2006 meeting in November. An advanced form was used to support both phantom and human studies in recent efforts conducted by researchers from the University of Tennessee and the University Tubingen and Max Planck Institute for Brain Research, both in Germany. Their work involved a combination of PET images produced with fluorine-18 and MR-generated T2 images.
The hybrid improves spatial correlation while reducing scan time compared to separate MR and PET imaging, the researchers said. Their paper, presented Thursday, May 24, at the ISMRM meeting in Berlin, described the use of lutetium-oxyorthosilicate (LSO) scintillation crystals in combination with next-generation Avalanche Photodiode Detector (APD) technology to capture PET data.
Five LSO-APD block detectors form 32 cassettes were arranged axially in Siemens' Trio MR scanner, creating an axial field-of-view of 19 cm and an inner ring diameter of 35.5 cm. A standard birdcage transmit/receive head coil from Siemens was mounted on the scanner bed and placed inside the PET detector to allow the simultaneous acquisition of PET and MR data.
The tests proved the feasibility of the hybrid scanner, according to the researchers. Images showed only the MR and PET data, as the PET detector was invisible during MR data acquisition. The detector also had no effect on either MR spectroscopy or MR signal-to-noise measurements, they reported.
More extensive testing using clinical subjects is expected to begin later this year.
Enhancing Lesions on Breast MRI: Can an Updated Kaiser Scoring Model Improve Detection?
September 26th 2024The addition of parameters such as patient age, MIP sign and associated imaging features to the Kaiser score demonstrated a 95.6 percent AUC for breast cancer detection of enhancing lesions on breast MRI in recently published research.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.